πŸ•΅οΈ Bioventus Inc. ($BVS)

SEC insider & ownership activity, last 12 months Β· CIK 1665988 Β· every row links its SEC filing

Over the last 12 months insiders sold $312K with no open-market buying against it. McMurry-Heath Michelle sold $237K in discretionary trades (Nov–Mar). No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net -$131K Dec 2025: net -$76K Jan 2026: net +$0 Mar 2026: net -$105K Mar 2026: net -$105K Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) Β· 2 sellers, $312K (3 lots)

InsiderBuysBoughtSellsSoldLast
McMurry-Heath Michelle0– 2$237KMar 11, 2026
Guy P. Nohra0– 1$76KDec 4, 2025

5%+ holders

HolderStakeClassScheduleEvent
Nantahala Capital Management, LLC 9.0% 13GFeb 13, 2026 filing β†—
Wilmot B. Harkey 9.0% 13GFeb 13, 2026 filing β†—
Daniel Mack 9.0% 13GFeb 13, 2026 filing β†—
Blackrock, Inc. 5.0% Class A13GJul 27, 2026 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
McMurry-Heath Michelle$106KMar 11, 2026 filing β†—
Guy P. Nohra$76KDec 4, 2025 filing β†—
McMurry-Heath Michelle$200KNov 7, 2025 filing β†—

Material events (8-K)

ItemEvent date
Shareholder vote (5.07)Jun 3, 2026 filing β†—
Reg FD disclosure (7.01)May 21, 2026 filing β†—
Earnings (2.02)May 6, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 6, 2026 filing β†—
Earnings (2.02)Mar 5, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 5, 2026 filing β†—
Officer/director changes (5.02)Nov 14, 2025 filing β†—
Earnings (2.02)Nov 4, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 4, 2025 filing β†—
Earnings (2.02)Aug 6, 2025 filing β†—
Financial Statements and Exhibits (9.01)Aug 6, 2025 filing β†—
Material agreement (1.01)Jul 31, 2025 filing β†—
New financial obligation (2.03)Jul 31, 2025 filing β†—
Financial Statements and Exhibits (9.01)Jul 31, 2025 filing β†—
Other events (8.01)Jul 30, 2025 filing β†—
Financial Statements and Exhibits (9.01)Jul 30, 2025 filing β†—